Image
An Israeli startup will be testing its cannabis-based treatments on children with autism. SciSparc aims to alleviate anxiety, sleep problems, hyperactivity, and other symptoms associated with the disorder. It will conduct a clinical trial to assess the safety, tolerability, and efficacy of its drug